In 2003, tfie city of Vancouver, British Columbia, opened North America's first government sanctioned safer injecting facility, where injection drug users (IDUs) can inject preobtained illicit drugs under the supervision of nurses. Use of the service by IDUs was followed by measurable reductions in public drug use and syringe sharing, IDUs who are frequently using the program tend to be high-intensity cocaine and heroin injectors and homeless individuals.
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The facility has provided high-risk IDUs a hygienic space where syringe sharing can be eliminated and the risk of fatal overdose reduced. Ongoing evaluation will be required to assess its impact on overdose rates and HIV infection levels, as well as its ability to improve IDU contact with medical care and addiction treat- 
ILUCIT INJECTION DRUG USE
has led to serious public health problems, such as HIV infection and overdoses, as well as major community concems, such as public injection drug use.'"** To address these concems, a number of European cities and Sydney, Australia, have opened safer injection facilities (SIFs), where injection drug users (IDUs} can inject preobtained illicit drugs,' Unfortunately, there is a dearth of quantitative evaluations of these facilities in the public bealth literature." In September 2003, Vancouver, British Columbia, Canada, opened North America's first government-sanctioned SIF in the city's Downtown Eastside (Figure 1) , The SIF, known as Insite, is lunded by Vancouver Coastal Health (the local health authority). We report on service uptake and client characteristics,
VANCOUVER SAFER INJECTING FACILITY
The Vancouver SIF began operating on September 22, 2003, and !S open daily between 10:00 AM and 4:00 , \M, 'I"he events leading to the program's implementation have recently been described,^ Within the SIF, IDUs are provided with sterile injecting equipment and emergency care in the event of overdose, as well as primary medical care services. In addition, an addictions counselor is available on site to meet with clients and to help facilitate referral to treatinent programs. To date there have been no major adverse events or harms among members of the Insite stalf."* The methodology for evaluating the SIF-through the recruitment of a representative cohort of SIF users, known as the Scientific Evaluation of Supervised Injecting (SEOSI) cohort-has recently been described in detail. We present cohort baseline characteristics and our examination of factors associated with reportIng daily SIE use at the time of participant's baseline interview. Variables of interest are listed in Tables 1 and 2 . and variable definitions were identical to those used in previous studies of Vancouver IDUs,'"""'^ Variables potentially associated with daily SIF use were examined in bivariate aiialyses.
DISCUSSION AND EVALUATION
The average number of daily visits to the SIF in its first week of operation was approximately 200; an approximate average of 500 visits per day has been consistently observed since the 2 months after the facility's opening. Diiring the latest 6 months for which data are available from the SIF database ( Note. HIV-human immunodeficiency virus; HCV-hepatitis C virus; Cl -confidence interval. Comparisons were done using the Pearson x^ test and the Wilcoxon rank sim test,The total does not add up to 713 for HIV and HCV hecajse full laboratory results were pending tor 3% of participants in the Scientffic Evaluation of Sipen/ised Injecting cohort, 'Proximity tclnsite.
15 decided not to enroll after learning what cohort participation would require. Overall, among the 713 participants who consented to enroU in the SHOSI cohort, 308 (43,2%) reported using the SIF daily at the time of their baseline interview.
Among the SEOSI cohort, 30% were women, and 19% selfidentified as Aboriginal, Interestingly, although venous blood samples intlicated that the hepatitis C virus prevalence was high at 88%, the HIV prevalence among SIF users was 16%, which is lower than HIV levels reported previously among the neighborhoods IDUs.'"• Overall, daily Insite users tended to be younger than nondaily users (38 years vs 40 years; P< ,001), A detailed presentation of client characteristics stratified hy daily SIF use is shown in Tables 1 and 2 ,
NEXT STEPS
It is noteworthy that several of the variables that were associated with frequent SIF use, including daily cocaine injection, daily heroin injection, and honielessness, have been previotisly associated with elevated rates of HIV infection among IDUs in Vancouver.'"'"' Because syringe sharing is precluded by SIF use, and as use of the site bas recently been associated with reduced syringe sharing,'' prospective foUow-up will be necessary to determine if greater exposure to the SIF is associated with reduced HIV incidence levels among this population."' IDUs requiring help with injections was negatively associated with SIF use, which is concerning because we have previousiy found that tiiis risk
KEY FINDINGS
• A medically supervised injection site staffed by nurses has been well accepted among IDUs in the community,
• Homelessness, which is commonly a factor in public injection drug use, was associated with frequent use ofthe SIF,
• Daily SIF use was associated witfi several risk betiaviors that have been linked to elevated rates of HIV transmission in this community. Including frequent cocaine injection.
• Prospective follow-up of SIF users will be valuable to examine blood-borne disease incidence and uptake of medical care and addiction treatment.
behavior is associated with elevated rates of syringe sharing and HIV infection among Vancouver IDUs.'" Feasibility studies indicated that IDUs who required help with injections would be less willing to use the facility if rules prohibited assisted injection, and it appears that this rule is reducing uptake among this high-risk population, ' ElTorts to accommodate those who require help with injections, through education or other inteiventions, should also be undertaken."^ It is also noteworthy that use of methadone was negatively associated with daily SIF use. However, this association is likely explained by the fact that methadone has been associated witb reduced demand for injection drugs rather than methadone use being a barrier to SIF use,^" This finding indicates that effoits to expand methadone use among opiate users in the communi^ should be increased, and futiire studies must examine the impact of tbe SIF on referrals to addiction treatment programs.'' Conversely, it is encouraging tliat daily use of the SIF was associated with several high-risk behaviors including cocaine injection and bomelessness. The fact that the daily SIF use was associated with homelessness is perhaps not suipnsing given that previous studies have indicated that SIF use may be associated with not having a safe place to inject.'^ Given that homeless persons may be more likely to inject in public, (he association between homelessness and frequent SIF use may partially explain why the opening of the SIF was linked to substantial reductions in public drug use."' Our study was limited by its cross-sectional study design and the evaluation is limited by its observational nature. Unfortunately, this cohort will have to be followed longitudinally for several years before an examination of blood-borne infection incidence will be possible, and it is likely that ethical concems will prevent interventional studies that randomize participants to SIF use VS nonuse.^^ Another limitation is that the evaluation largely relies on seif-repoil; therefore, it is likely that we have underestimated socially undesirable behaviors, such as syringe sharing.^'' Finally, frequent use of the SIF was on the basis of self-report and was measured cross-sectionally at the time of recruitment into the stiidy. Future studies examining exposure to the SIF will require prospective examination of SIF use through the use of the SIF database.
This report is the first presentation of the sociodemographic and risk characteristics of a representative sample of SIF users in the public health literature. Our study indicates that the SIF was well accepted by high-risk IDUs in the community and that frequent use is characterized by homelessness and high-intensity drug use, induding cocaine injection. The site's opening was recently associated with improved public order and reduced syringe sharing,''^' and it is noteworthy that frequent use was associated with homelessness in the present study because homeless drug users may be particularly prone to public drug use,"^ Although these preliminary findings are encouraging, prospective evaluation of SIF users wili be required to examine the impact of SIF use on a number of outcomes, such as rates of blood-borne infections. In addition, program rules that may create barriers to uptake must be further examined.
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